Shashoua; Victor E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shashoua; Victor E..The latest application filed is for "neuroprotective and neurorestorative methods and compositions".

Company Profile

0.28.14

Shashoua; Victor E. - Brookline MA
Shashoua, Victor E. - Belmont MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Neuroprotective and neurorestorative methods and compositions Grant 9,295,707 - Shashoua March 29, 2	2016-03-29
Compositions and methods for counteracting effects of reactive oxygen species and free radicals Grant 8,772,237 - Shashoua July 8, 2	2014-07-08
Neuroprotective And Neurorestorative Methods And Compositions App 20140018300 - SHASHOUA; VICTOR E.	2014-01-16
Neuroprotective and neurorestorative method and compositions Grant 8,507,439 - Shashoua August 13, 2	2013-08-13
Fatty acid-pharmaceutical agent conjugates Grant 8,314,077 - Webb , et al. November 20, 2	2012-11-20
Compositions And Methods For Counteracting Effects Of Reactive Oxygen Species And Free Radicals App 20120058957 - Shashoua; Victor E.	2012-03-08
Neuroprotective and neurorestorative method and compositions App 20120027781 - Shashoua; Victor E. ; et al.	2012-02-02
Compositions and methods for counteracting effects of reactive oxygen species and free radicals Grant 8,034,774 - Shashoua October 11, 2	2011-10-11
Compositions and methods for counteracting effects of reactive oxygen species and free radicals Grant 7,524,819 - Shashoua April 28, 2	2009-04-28
Compositions and methods for counteracting effects of reactive oxygen species and free radicals App 20090082281 - Shashoua; Victor E.	2009-03-26
DHA-pharmaceutical agent conjugates of taxanes Grant 7,199,151 - Shashoua , et al. April 3, 2	2007-04-03
Peptide dependent upregulation of telomerase expression App 20070042962 - Adams; David S. ; et al.	2007-02-22
Compositions and methods for counteracting effects of reactive oxygen species and free radicals App 20060019901 - Shashoua; Victor E.	2006-01-26
Peptide compounds for counteracting reactive oxygen species and free radicals App 20050130902 - Shashoua, Victor E.	2005-06-16
Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals App 20050130881 - Shashoua, Victor E.	2005-06-16
Compositions and methods for counteracting effects of reactive oxygen species and free radicals Grant 6,890,896 - Shashoua May 10, 2	2005-05-10
Compositions and methods for counteracting effects of reactive oxygen species and free radicals App 20050090446 - Shashoua, Victor E.	2005-04-28
Neuroprotective peptides and uses thereof App 20050004019 - Shashoua, Victor E.	2005-01-06
DHA-pharmaceutical agent conjugates of taxanes App 20040180949 - Shashoua, Victor E. ; et al.	2004-09-16
Fatty acid-pharmaceutical agent conjugates App 20040106589 - Webb, Nigel L. ; et al.	2004-06-03
Dha-pharmaceutical agent conjugates to improve tissue selectivity Grant 6,602,902 - Shashoua , et al. August 5, 2	2003-08-05
Method of treating a liver disorder with fatty acid-antiviral agent conjugates Grant 6,576,636 - Webb , et al. June 10, 2	2003-06-10
Dopamine analog amide App 20030050226 - Shashoua, Victor E.	2003-03-13
Dopamine analog amide Grant 6,407,137 - Shashoua June 18, 2	2002-06-18
Dopamine analog amide Grant 6,258,836 - Shashoua July 10, 2	2001-07-10
Fatty acid-pharmaceutical agent conjugates App 20010002404 - Webb, Nigel L. ; et al.	2001-05-31
Neuroprotective peptides and uses thereof Grant 6,225,444 - Shashoua May 1, 2	2001-05-01
Clozapine compositions and uses thereof Grant 6,197,764 - Bradley , et al. March 6, 2	2001-03-06
Choline compositions and uses thereof Grant 6,153,653 - Shashoua November 28, 2	2000-11-28
Dopamine analog amide Grant 6,107,499 - Shashoua August 22, 2	2000-08-22
Taxanes Grant 6,080,877 - Swindell , et al. June 27, 2	2000-06-27
Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid Grant 5,994,392 - Shashoua November 30, 1	1999-11-30
Cholinergic compositions and uses thereof Grant 5,977,174 - Bradley , et al. November 2, 1	1999-11-02
Fatty acid-antipsychotic compositions and uses thereof Grant 5,955,459 - Bradley , et al. September 21, 1	1999-09-21
Taxane compounds and compositions Grant 5,919,815 - Bradley , et al. July 6, 1	1999-07-06
DHA-pharmaceutical agent conjugates of taxanes Grant 5,795,909 - Shashoua , et al. August 18, 1	1998-08-18
Nerve growth peptides Grant 5,545,719 - Shashoua August 13, 1	1996-08-13
Method of treating tardive dyskinesia using dopaminergic agents of prodrugs of therapeutic agents Grant 5,284,876 - Shashoua , et al. February 8, 1	1994-02-08
GABA esters and GABA analog esters Grant 5,051,448 - Shashoua September 24, 1	1991-09-24
Appetite suppression with dopamine-fatty acid conjugates Grant 4,939,174 - Shashoua July 3, 1	1990-07-03
Fatty acid-neuroactive drug conjugate as a prodrug Grant 4,933,324 - Shashoua June 12, 1	1990-06-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.